Can lamotrigine cause urinary retention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Lamotrigine Cause Urinary Retention?

No, lamotrigine does not typically cause urinary retention, but there is emerging evidence suggesting a possible association with urinary incontinence rather than retention.

Evidence Analysis

Direct Evidence on Lamotrigine and Urinary Symptoms

The most relevant evidence comes from a large population-based study that found lamotrigine was associated with urinary incontinence (UI), not urinary retention 1. In this study of 21,735 women, those using lamotrigine had an odds ratio of 2.73 (95% CI: 1.59-4.68) for experiencing UI when filling two or more prescriptions. The association was most pronounced for mixed UI and in women with severe symptoms 1.

Importantly, lamotrigine was NOT identified as a drug causing urinary retention in comprehensive systematic reviews of drug-induced urinary retention 2, 3. These reviews specifically examined antipsychotics, antidepressants, anticholinergics, opioids, and other medication classes known to cause retention, but lamotrigine was absent from these analyses.

Mechanism Considerations

The urodynamic research provides insight into lamotrigine's actual effects on bladder function. In an animal model of neurogenic detrusor overactivity, lamotrigine actually improved bladder capacity and reduced detrusor overactivity 4. At a dose of 3 mg/kg, lamotrigine increased bladder capacity from 0.45 ml to 0.7-0.8 ml and reduced frequency of detrusor overactivity from 3.7/min to 1.9/min. This mechanism would theoretically reduce, not increase, the risk of urinary retention.

Distinguishing Retention from Incontinence

It is critical to understand that:

  • Urinary retention = inability to empty the bladder, resulting in elevated post-void residual urine
  • Urinary incontinence = involuntary leakage of urine

These are opposite conditions. The evidence suggests lamotrigine may be associated with incontinence (leakage), not retention (inability to void).

Clinical Implications

Risk Assessment

  • Lamotrigine does not appear on validated lists of medications causing urinary retention 2, 3, 5
  • The FDA label for lamotrigine does not list urinary retention as a known adverse effect 6
  • If a patient on lamotrigine develops urinary retention, investigate other causes first:
    • Anticholinergic medications (antipsychotics, antidepressants, antihistamines)
    • Alpha-agonists
    • Opioids
    • Benign prostatic hyperplasia in men
    • Neurological conditions

What to Monitor Instead

Based on the evidence, clinicians should be aware that lamotrigine may be associated with:

  • Urinary incontinence, particularly mixed type 1
  • Urinary tract infections (noted in pediatric tolerability studies) 7
  • The association is stronger in women and with higher cumulative exposure 1

Common Pitfalls

  1. Confusing incontinence with retention: These require opposite management approaches
  2. Polypharmacy effects: Many patients on lamotrigine take other medications (antidepressants, antipsychotics) that DO cause retention 3
  3. Age-related factors: Elderly patients may have baseline prostatic hyperplasia or detrusor dysfunction independent of lamotrigine 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.